Position in ZTS
as of Mar 31, 2026
· filed Apr 6, 2026
Position Value
$118,682
-$7,641 QoQ
Shares Held
1,004
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Washington Trust Advisors, Inc. holds $218,919 across 5 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (54.2% of the industry book) .
All Filings in ZTS
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $118,682 | 1,004 | Shares | Sole | 2026-04-06 | |
| 2025-12-31 | $126,323 | 1,004 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $146,905 | 1,004 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $154,546 | 991 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $163,168 | 991 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $31,119 | 191 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $37,317 | 191 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $33,111 | 191 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $38,410 | 227 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $44,802 | 227 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $39,493 | 227 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $40,985 | 238 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $77,061 | 463 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $127,058 | 867 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $303,400 | 2,046 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $392,595 | 2,284 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $396,416 | 2,102 | Shares | Other | 2022-05-05 | |
| 2021-12-31 | $574,689 | 2,355 | Shares | Other | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||